Literature DB >> 9474316

Sulphur hexafluoride in the treatment of flat anterior chamber following trabeculectomy.

B Beigi1, M O'Keefe, K Algawi, R Acheson, J Burke.   

Abstract

The efficacy and side effects of sulphur hexafluoride (SF6) in the reformation of the flat anterior chamber (AC) after standard trabeculectomies were studied. Ten patients with lenticulocorneal touch following trabeculectomy were enrolled. All had water-tight conjunctival wounds with overflowing fistulas. In 5, one to four surgical attempts to reform the AC were unsuccessful. Two to seven days after trabeculectomy, the AC was reformed by a single injection of SF6/air mixture (20-40%). Gas was injected through the limbus at 3 or 9 o'clock. The AC remained deep after absorption of the gas in 2-7 days. All patients had stromal oedema in the first 4 days. This resolved and specular microscopy did not show any abnormality. After a mean follow-up of 2.5 years, all had normal intraocular pressure, 3 with one topical antiglaucoma treatment. Three patients developed cataracts before and 3 after reformation of the AC. The latter 3 were not anterior capsular cataracts as induced by gases. SF6/air mixture (20-40%) is inert and kind to the cornea and, as it is absorbed in less than 7 days, it exerts minimal damage to the crystalline lens. It is effective in the reformation of flat ACs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9474316     DOI: 10.1038/eye.1997.175

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

1.  Combined perfluoropropane gas and viscoelastic material injection for anterior chamber reformation following trabeculectomy.

Authors:  S Kurtz; I Leibovitch
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

2.  Lens Extraction for Management of Coexisting Cataract and Post-filtering Surgery Ocular Hypotony.

Authors:  Ghasem Fakhraie; Zahra Mohajernezhad-Fard; Sasan Moghimi; Zakieh Vahedian; Yadollah Eslami; Reza Zarei
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.